Sarah Watmough is currently working as a Lecturer in Nursing within the Postgraduate nursing team at Liverpool John Moores University.
Sarah began this academic role in 2024, after over twenty years of clinical practice working within the field of Haematology. Her clinical career began working as a staff nurse within the Bone Marrow Transplant Unit and Haematology wards in the Royal Liverpool University Hospital. She then progressed to a senior nurse level and was then seconded to support the myeloid research team in a role as a Research Nurse with a focus on research in the field of Chronic Myeloid Leukaemia (CML). She then undertook her Masters in Research (MRes) in 2010 through an NIHR programme and gained great experience undertaking research into cancer survivorship using narrative research and also gained a publication of a literature review evaluating pain management strategies for patients undergoing a bone marrow biopsy. Sarah then returned to clinical practice in a dual role as a research nurse and specialist nurse, within the field of Acute Myeloid Leukaemia (AML), gaining further experience working as a research nurse within phase 1-3 clinical trials. She was also the key worker for all the patients on her trials, responsible for extended roles such as medication prescribing and consenting for chemotherapy. During this time her skills as a specialist nurse were also developed undertaking further qualifications in Clinical Examination, Diagnostics and Prescribing. The post was transferred over to Clatterbridge Cancer Centre in 2018 with the merge of Haematology and Oncology within Clatterbridge and this post continued until her new role as a Lecturer began at the end of 2024.
Sarah has always had an active interest in research throughout her career, not only within her role as a Research Nurse but within her own other areas of interest. Following her MRes she has worked with a team of researchers between Clatterbridge and John Moores University on projects exploring the well-being of cancer nurses following the COVID-19 pandemic. She has also worked as a Principal Investigator on a medication adherence study within CML and most recently leading on the PROPEL study in Clatterbridge, an NIHR prehabilitation study for patients with AML. This has also led to a keen interest in prehabilitation in cancer care.
Sarah is excited to be undertaking this new role as a Lecturer in Nursing and plans further involvement in her own and team research projects. She continues to work with the team from Clatterbridge currently supporting a study exploring the experiences of informal carer’s who provide help to a person with cancer with a health condition of their own. She is also a member of her faculty’s research group supporting the theme Promoting Physical, Mental and Social wellbeing.
Degrees
2010, University of Liverpool, United Kingdom, Masters in Research
2002, University of Liverpool, United Kingdom, Bachelor of Nursing
Certifications
2023, University of Liverpool, United Kingdom, Developing Practice in Palliative and End of Life care
2018, Liverpool John Moores University, United Kingdom, Independent and Supplementary Prescribing
2013, Liverpool John Moores University, United Kingdom, Clinical Diagnostics
2009, Liverpool John Moores University, United Kingdom, Clinical Examination
2005, Liverpool John Moores University, United Kingdom, High Dependency Nursing
2004, Liverpool John Moores University, United Kingdom, Mentorship in Clinical Practice
Academic appointments
Lecturer in Nursing, Liverpool John Moores University, Liverpool John Moores University, 2024 - present
Journal article
Appleton L, Atkins C, Watmough S, Cherry MG, Poole H. 2023. Exploring the impact of COVID-19 on the psychological well-being of oncology healthcare professionals Journal of Advanced Nursing, 79 :3787-3799 DOI Author Url Publisher Url Public Url
Francis S, Lucas C, Lane S, Wang L, Watmough S, Knight K, Bell J, Kaleel-Rahman M, Lee E, O'Brien D, Butt NM, Sadik W, De Soysa L, Seale JRC, Salim R, Clark RE. 2013. A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia. Leukemia research, 37 :752-758 DOI Author Url Publisher Url
Watmough S, Flynn M. 2011. A review of pain management interventions in bone marrow biopsy. Journal of clinical nursing, 20 :615-623 DOI Author Url Publisher Url
Estabragh ZR, Knight K, Watmough SJ, Lane S, Vinjamuri S, Hart G, Clark RE. 2011. A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib. Leukemia research, 35 :49-51 DOI Author Url Publisher Url
Wright A, Flynn M, Watmough S, Fry K. 2010. Ethical aspects of health research British Journal of Cardiac Nursing, 5 :444-450 DOI Publisher Url
Watmough S, Flynn M, Wright A, Fry K. 2010. Research nurse or nurse researcher? British Journal of Cardiac Nursing, 5 :396-399 DOI Publisher Url
Flynn M, Watmough S, Wright A, Fry K. 2010. Health research in context, defining the research question and designing the study British Journal of Cardiac Nursing, 5 :346-349 DOI Publisher Url
Davies A, Hayes AK, Knight K, Watmough SJ, Pirmohamed M, Clark RE. 2010. Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography. Leukemia research, 34 :702-707 DOI Author Url Publisher Url
Lucas CM, Harris RJ, Giannoudis A, Knight K, Watmough SJ, Clark RE. 2010. BCR-ABL1 tyrosine kinase activity at diagnosis, as determined via the pCrkL/CrkL ratio, is predictive of clinical outcome in chronic myeloid leukaemia. British journal of haematology, 149 :458-460 DOI Author Url Publisher Url
Lucas CM, Harris RJ, Giannoudis A, Davies A, Knight K, Watmough SJ, Wang L, Clark RE. 2009. Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript. Haematologica, 94 :1362-1367 DOI Author Url Publisher Url